![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. R 147681
2. R-147681
3. Tmc 120
4. Tmc-120
5. Tmc120-r147681
1. 244767-67-7
2. Tmc-120
3. Dapivirine (tmc120)
4. Tmc120
5. Dapivirinum
6. Tmc 120
7. R 147681
8. R-147681
9. 4-[[4-(2,4,6-trimethylanilino)pyrimidin-2-yl]amino]benzonitrile
10. Tmc120-r147681
11. R147681
12. Dapivirine,tmc-120
13. Benzonitrile, 4-[[4-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]-
14. Tcn4mg2vxs
15. Aids-105293
16. Gel-02
17. 4-({4-[(2,4,6-trimethylphenyl)amino]pyrimidin-2-yl}amino)benzonitrile
18. 4-[[4-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzonitrile
19. 4-[4-(2,4,6-trimethyl-phenylamino)-pyrimidin-2-ylamino]-benzonitrile
20. 4-((4-(mesitylamino)pyrimidin-2-yl)amino)benzonitrile
21. Tmc120;r147681
22. 4-((4-((2,4,6-trimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile
23. Dapivirine [inn]
24. Unii-tcn4mg2vxs
25. Dapivirine [usan:inn]
26. Gel-002
27. Dapivirine-[d11]
28. Dapivirine(tmc120)
29. Tmc-120/r-147681
30. Ring-004
31. Dapivirine (usan/inn)
32. Dapivirine [usan]
33. 4-({4-[(2,4,6-trimethylphenyl)amino]pyrimidin-2-yl}amino)benzenecarbonitrile
34. Dapivirine Intravaginal Ring
35. Dapivirine [who-dd]
36. Chembl70663
37. Schembl383370
38. Zinc7761
39. Dtxsid40179244
40. Ex-a115
41. Hms3651j10
42. Bcp06491
43. Bdbm50467334
44. Mfcd09833899
45. S2914
46. Akos016513117
47. Ccg-267802
48. Db08639
49. Dt-0051
50. Sb16698
51. Dapivirine,4-[[4-(2,4,6-trimethylphenyl)amino]pyrimidin-2-yl]amino]benzonitrile
52. Ncgc00371120-06
53. Ac-30627
54. Hy-14266
55. Ft-0665472
56. Sw220193-1
57. D11246
58. 4-(4-(mesitylamino)pyrimidin-2-ylamino)benzonitrile
59. J-690269
60. Q27097831
61. 4-[[4-[(2,4,6-trimethylphenyl)-amino]-2-pyrimidinyl]amino]benzonitrile
62. 4-[[4-[(2,4,6trimethylphenyl)amino]-2-pyrimidinyl]amino]benzonitrile
63. 4-[[4[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzonitrile
Molecular Weight | 329.4 g/mol |
---|---|
Molecular Formula | C20H19N5 |
XLogP3 | 4.8 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | 329.16404563 g/mol |
Monoisotopic Mass | 329.16404563 g/mol |
Topological Polar Surface Area | 73.6 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 452 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-HIV Agents
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)
G - Genito urinary system and sex hormones
G01 - Gynecological antiinfectives and antiseptics
G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids
G01AX - Other antiinfectives and antiseptics
G01AX17 - Dapivirine